<b>Risk Factors for the Prolongation of Activated Partial Thromboplastin Time Associated with Dabigatran Therapy in Patients with Non-Valvular Atrial Fibrillation</b>
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.